StockData
Amgen Inc logo

Amgen Inc

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)

Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%

Amgen Staff Members Located Outside the United States by Year

Staff Members Located Outside the United States (employees)

Amgen Staff Members Located Outside the United States: 13,000 in FY2025, up 18.2% from a year earlier.

Latest, FY2025
13,000
Period ended Dec 31, 2025
Change on a year earlier
+18.2%
11,000 in FY2024
History
2 years
Since FY2024
Sources
2
Documents cited below

Where the FY2025 figure comes from

“As of December 31, 2025, Amgen had approximately 31,500 staff members in over 50 countries, including approximately 13,000 staff members outside the United States, and we continue to experience overall low turnover rates.”

Source: Form 10-K (amgn-20251231.htm, filed 2026-02-13) ↗

Reported in Form 10-K Item 1 Business — Human Capital & International Operations.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedStaff Members Located Outside the United States (employees)Year on yearSource
FY2025Dec 31, 202513,000+18.2%Form 10-K (amgn-20251231.htm, filed 2026-02-13) ↗
FY2024Dec 31, 202411,000–Form 10-K (amgn-20241231.htm, filed 2025-02-14) ↗

Cite this data

StockData. (2026). Amgen Staff Members Located Outside the United States, annual FY2024–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/hc-nonus-staff

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.